Assignee
DAS MG INC
US·5 granted patents·3 pending applications·1 citations·filing 2018–2025
Top patents by PatentIndex Score
8 records- 0184US10842778B2Use and composition for treating myasthenia gravis and other myasthenic syndromesDAS MG INC·Filed 2019·Granted Nov 24, 2020·1 cites·17 claims
- 0275US2025288545A1Neostigmine combinations and compositionsDAS MG INC·Filed 2025·Application pending·0 cites
- 0373US12023315B2Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravisDAS MG INC·Filed 2022·Granted Jul 2, 2024·0 cites·12 claims
- 0471US11896582B2Use and composition for treating myasthenia gravis and other myasthenic syndromesDAS MG INC·Filed 2020·Granted Feb 13, 2024·0 cites·5 claims
- 0568US2021260004A1Neostigmine combination and compositionsDAS MG INC·Filed 2021·Application pending·0 cites
- 0664US11389420B2Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravisDAS MG INC·Filed 2020·Granted Jul 19, 2022·0 cites·19 claims
- 0762US2020054611A1Use and composition for treating myasthenia gravis and other myasthenic syndromesDAS MG INC·Filed 2018·Application pending·0 cites
- 0858US11752141B2Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravisDAS MG INC·Filed 2020·Granted Sep 12, 2023·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when DAS MG INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →